We are live on ! Find out more
DRIO icon

DarioHealth

58 hedge funds and large institutions have $58M invested in DarioHealth in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.37% less ownership

Funds ownership: 2.52%2.15% (-0.37%)

6% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 17

8% less funds holding

Funds holding: 6358 (-5)

9% less capital invested

Capital invested by funds: $63.7M → $58M (-$5.71M)

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

54% less call options, than puts

Call options by funds: $262K | Put options by funds: $570K

Holders
58
Holders Change
-5
Holders Change %
-7.94%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
16
Reduced
17
Closed
19
Calls
$262K
Puts
$570K
Net Calls
-$308K
Net Calls Change
+$142K
Name Holding Trade Value Shares
Change
Change in
Stake
CAL
76
Capital Advisors Ltd
Ohio
+$235 +2 New

DRIO Hedge Fund Activity: Q2 2022 in Review

58 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2022, worth a combined $58M — down 9% from $63.7M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of DRIO and 15 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 16 added.

The largest buyer was Millennium Management, adding an estimated $2.52M. The largest seller was BlackRock, cutting an estimated $3.8M.

  • 58 institutional investors held DarioHealth (DRIO) as of Q2 2022, down from 63 in Q1 2022.
  • Funds reported $58M of DarioHealth stock for Q2 2022, down 9% quarter-over-quarter.
  • 15 funds opened new DarioHealth positions in Q2 2022 and 19 closed out, a net change of -4 holders.
  • The largest DarioHealth buyer in Q2 2022 was Millennium Management, an estimated $2.52M added.
  • The largest DarioHealth seller in Q2 2022 was BlackRock, an estimated $3.8M sold.

Based on aggregated 13F filings for Q2 2022.